Login
Section Articles

Gender Differences in Metabolic Syndrome Risk Factors Based on International Diabetes Federation Criteria

Vol. 3 No. 1 (2026): July:

Khamail A. Bader (1), Majid A. Maatook (2), Ibrahim A. Zaboon (3)

(1) Department of Community Health Techniques, College of Health & Medical Techniques, Southern Technical University, Basra, Iraq
(2) Department of Artificial Kidney Techniques, College of Health & Medical Techniques, Southern Technical University, Basra, Iraq
(3) Al-Basra Health Directorate/Al-Faiha Specialized Diabetes, Endocrine and Metabolism Center, Basra, Iraq
Fulltext View | Download

Abstract:

General Background: Metabolic syndrome (MetS) represents a cluster of interrelated metabolic and cardiovascular risk factors that substantially increase morbidity and mortality worldwide. Specific Background: In Iraq, the rising burden of non-communicable diseases has intensified interest in MetS, yet evidence on gender-specific risk patterns using International Diabetes Federation (IDF) criteria remains limited. Knowledge Gap: Few studies have systematically examined gender differences in MetS risk factors among Iraqi adults. Aims: This study aimed to identify and compare gender-specific risk factors for MetS among adults in Al-Basra province based on IDF criteria. Results: Distinct gender differences were observed in sociodemographic characteristics, anthropometric measures, lipid profiles, blood pressure, smoking status, and family history patterns, while age, residence, body mass index, glycemic status, and physical activity showed no significant gender differences. Novelty: The study provides localized, gender-stratified evidence on MetS risk factors in southern Iraq. Implications: The findings support the need for gender-sensitive prevention, screening, and management strategies within primary care and public health programs.
Keywords : Metabolic Syndrome, Gender Differences, Risk Factors, International Diabetes Federation Criteria, Waist Circumference
Highlight :












  • Females showed higher LDL, HDL, and familial hypertension, diabetes, and cardiovascular histories.




  • Males exhibited greater waist measurements, smoking prevalence, and familial obesity history.




  • Anthropometric measures differed by sex, while body mass index and physical activity remained comparable.











References

R. Kelishadi, S. Hovsepian, S. Djalalinia, F. Jamshidi, and M. Qorbani, “A Systematic Review on the Prevalence of Metabolic Syndrome in Iranian Children and Adolescents,” Journal of Research in Medical Sciences, vol. 21, no. 1, pp. 1–10, 2016, doi: 10.4103/1735-1995.181989.

T. D. Dagpo, C. J. Nolan, and V. Delghingaro-Augusto, “Exploring Therapeutic Targets to Reverse or Prevent the Transition From Metabolically Healthy to Unhealthy Obesity,” Cells, vol. 9, no. 7, p. 1596, 2020, doi: 10.3390/cells9071596.

E. Adnan, I. A. Rahman, and H. P. Faridin, “Relationship Between Insulin Resistance, Metabolic Syndrome Components and Serum Uric Acid,” Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol. 13, no. 3, pp. 2158–2162, 2019, doi: 10.1016/j.dsx.2019.05.010.

E. McCracken, M. Monaghan, and S. Sreenivasan, “Pathophysiology of the Metabolic Syndrome,” Clinics in Dermatology, vol. 36, no. 1, pp. 14–20, 2018, doi: 10.1016/j.clindermatol.2017.09.004.

J. H. Huh, D. R. Kang, J. Y. Kim, and K. K. Koh, “Metabolic Syndrome Fact Sheet 2021: Executive Report,” CardioMetabolic Syndrome Journal, vol. 1, no. 1, pp. 1–8, 2021, doi: 10.51789/cmsj.2021.1.e1.

C. Reisinger, B. N. Nkeh-Chungag, P. M. Fredriksen, and N. Goswami, “The Prevalence of Pediatric Metabolic Syndrome—A Critical Look on the Discrepancies Between Definitions and Its Clinical Importance,” International Journal of Obesity, vol. 45, no. 1, pp. 12–24, 2021, doi: 10.1038/s41366-020-00713-1.

S. M. Grundy, “Metabolic Syndrome Pandemic,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 4, pp. 629–636, 2008, doi: 10.1161/ATVBAHA.107.151092.

A. A. Saleh, A. H. Hayawi, A. Y. Al-Samarrai, and R. K. Lafta, “Metabolic Syndrome Among Obese Adults in Baghdad, Iraq,” Saudi Journal of Obesity, vol. 5, no. 1, pp. 8–13, 2017, doi: 10.4103/sjo.sjo_6_17.

H. Y. Ngai, K. K. S. Yuen, C. M. Ng, C. H. Cheng, and S. K. P. Chu, “Metabolic Syndrome and Benign Prostatic Hyperplasia: An Update,” Asian Journal of Urology, vol. 4, no. 3, pp. 164–173, 2017, doi: 10.1016/j.ajur.2017.05.003.

T. Unger et al., “2020 International Society of Hypertension Global Hypertension Practice Guidelines,” Hypertension, vol. 75, no. 6, pp. 1334–1357, 2020, doi: 10.1161/HYPERTENSIONAHA.120.15026.